灵芝三萜类化合物抗癌作用机制的研究进展(英文)

被引:27
作者
刘高强 [1 ]
丁重阳 [2 ]
王晓玲 [1 ]
机构
[1] 中南林业科技大学生命科学与技术学院
[2] 江南大学生物工程学院
关键词
LLC;
D O I
10.13346/j.mycosystema.2007.03.023
中图分类号
R285 [中药药理学];
学科分类号
1008 ;
摘要
<正>INTRODUCTION Ganoderma lucidum(Fr.)P.Karst.,a species of higher fungus called"Lingzhi"in Chinaor"Reishi"and"Mannendake"in Japan,has been used in the traditional Chinese medicine(TCM)for prevention and treatment
引用
收藏
页码:470 / 476
页数:7
相关论文
共 26 条
[1]   几种昆虫水提和醇提物对灵芝深层发酵生产多糖的影响(英文) [J].
刘高强 ;
章克昌 .
菌物学报, 2006, (02) :308-315
[2]   灵芝三萜类成分研究进展 [J].
高建莉 ;
禹志领 ;
李绍平 ;
王一涛 .
中国食用菌, 2005, (04) :6-11
[3]   灵芝抗肿瘤活性和免疫调节作用的研究进展 [J].
林志彬 .
北京大学学报(医学版), 2002, (05) :493-498
[4]   灵芝三萜化学成分研究进展 [J].
陈若芸 ;
于德泉 .
药学学报, 1990, (12) :940-953
[5]  
Prevention of nephrotoxicity induced by the anticancer drug cisplatin, using Ganoderma lucidum, a medicinal mushroom occurring in South India[J].Current Science,2003
[6]   Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest [J].
Lin, SB ;
Li, CH ;
Lee, SS ;
Kan, LS .
LIFE SCIENCES, 2003, 72 (21) :2381-2390
[7]   Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma [J].
Casson, AG ;
Zheng, Z ;
Chiasson, D ;
MacDonald, K ;
Riddell, DC ;
Guernsey, JR ;
Guernsey, DL ;
McLaughlin, J .
CANCER DETECTION AND PREVENTION, 2003, 27 (02) :139-146
[8]  
L. Reddy,B. Odhav,K.D. Bhoola.Natural products for cancer prevention: a global perspective[J].Pharmacology and Therapeutics,2003(1)
[9]  
Xing-Feng Bao,Xue-Song Wang,Qun Dong,Ji-Nian Fang,Xiao-Yu Li.Structural features of immunologically active polysaccharides from Ganoderma lucidum[J].Phytochemistry,2002
[10]  
Xin Liu,Jian-Ping Yuan,Chee-Keung Chung,Xiao-Jun Chen.Antitumor activity of the sporoderm-broken germinating spores of Ganoderma lucidum[J].Cancer Letters,2002